Sennosides (Senekot) Laxative Overview
Uploaded by
megSennosides (Senekot) Laxative Overview
Uploaded by
megCommon questions
Powered by AISennosides, active compounds in Senekot, act as stimulant laxatives by irritating and stimulating intestinal cells. This irritation leads to increased contractions of the intestines, promoting an influx of water to the intestines and ultimately causing bowel movements. It is used to alleviate constipation by inducing these physiological changes, facilitating easier transit of stools through the colon .
Excessive loss of water and electrolytes can occur due to the increased bowel movements and water influx into the intestines caused by Sennosides. This can lead to dehydration, electrolyte imbalances such as hypokalemia, and an overall disruption of metabolic functions if not monitored and managed properly, placing patients at risk for serious complications .
Nursing responsibilities include assessing and reducing the dose for patients experiencing significant abdominal cramping. Nurses should educate patients on the potential for urine and feces color change, the risk of laxative dependence from continued use, and advise them to seek medical consultation if constipation persists. Additionally, they should be informed not to breastfeed while taking the medication .
Continued use of Sennosides can lead to laxative dependence, meaning the bowel may become reliant on the stimulant to function normally, leading to potential chronic constipation issues without the drug. Patients should be advised to consult a physician if constipation persists, to identify and treat any underlying causes rather than continue long-term use of the laxative .
Both Sennosides (Senekot) and Bisacodyl are stimulant laxatives that work by irritating the intestinal lining to promote bowel movements. However, Sennosides are natural compounds derived from the senna plant, while Bisacodyl is a synthetic compound. Their nursing implications are similar, involving monitoring for effective relief of constipation while avoiding adverse effects like cramping and dependence. However, the natural derivation of Sennosides might appeal to patients preferring plant-based treatments .
Pregnancy category C indicates that there are no adequate and well-controlled studies in pregnant women, and Sennosides should only be used if the potential benefits justify the potential risk to the fetus. This classification requires careful consideration by healthcare providers to weigh the potential risks against benefits when prescribing this medication to pregnant patients .
Sennosides are contraindicated in cases of undiagnosed abdominal pain or intestinal obstruction because the stimulant effect, which increases intestinal contractions, could exacerbate these conditions. In the presence of intestinal obstruction, stimulating intestinal motility may worsen the blockage, leading to potential complications like perforation. Undiagnosed abdominal pain might obscure more serious underlying conditions that require specific treatments other than laxatives .
While taking Sennosides, a patient may notice a color change in urine and feces to yellowish brown in acidic medium and reddish brown in alkaline conditions. These changes are due to metabolites of the drug and generally do not pose health threats. However, if patients are concerned, they should discuss this with their healthcare provider for reassurance .
Breastfeeding is not advised while taking Sennosides because the compounds can be excreted in breast milk and may potentially cause laxative effects in the breastfed infant. To avoid these side effects, alternative treatments should be considered, or breastfeeding should be paused during treatment with Sennosides .
In patients experiencing significant abdominal cramping, the dose of Sennosides should be reduced. This is to minimize the discomfort and potential for adverse reactions related to excessive stimulation of the intestinal tract, which can lead to severe cramps and diarrhea .